Phase 2 COPD
Research Grant
Awarded By
Pfizer, Inc.
Start Date
November 14, 2024
End Date
December 1, 2024
Awarded By
Pfizer, Inc.
Start Date
November 14, 2024
End Date
December 1, 2024